rs1476214

Variant names:

• chr4-122891854-G-A
• rs1476214
• NM_001361665.2:c.283-357G>A

Your query was ambiguous. Multiple possible variants found:

• chr4-122891854-G-A
• chr4-122891854-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001361665.2(FGF2):​c.283-357G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.47 in 151,960 control chromosomes in the GnomAD database, including 18,238 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.47 (18238 hom., cov: 32)
• Consequence: FGF2 NM_001361665.2 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.470
• Publications: 4 publications found

Genes affected

FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]

NUDT6 (HGNC:8053): (nudix hydrolase 6) This gene overlaps and lies on the opposite strand from FGF2 gene, and is thought to be the FGF2 antisense gene. The two genes are independently transcribed, and their expression shows an inverse relationship, suggesting that this antisense transcript may regulate FGF2 expression. This gene has also been shown to have hormone-regulatory and antiproliferative actions in the pituitary that are independent of FGF2 expression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.96).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.673 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
FGF2	NM_001361665.2	c.283-357G>A		intron_variant	Intron 2 of 2	ENST00000644866.2	NP_001348594.1
FGF2	NM_002006.6	c.682-357G>A		intron_variant	Intron 2 of 2		NP_001997.5

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
FGF2	ENST00000644866.2	c.283-357G>A		intron_variant	Intron 2 of 2		NM_001361665.2	ENSP00000494222.1
FGF2	ENST00000264498.9	c.682-357G>A		intron_variant	Intron 2 of 2	1		ENSP00000264498.4
FGF2	ENST00000608478.1	c.283-357G>A		intron_variant	Intron 2 of 2	1		ENSP00000477134.1
NUDT6	ENST00000608639.1	n.57+778C>T		intron_variant	Intron 1 of 2	3

Frequencies

GnomAD3 genomes AF: 0.470 AC: 71345 AN: 151842 Hom.: 18205 Cov.: 32

Gnomad AFR AF: 0.679

Gnomad AMI AF: 0.378

Gnomad AMR AF: 0.378

Gnomad ASJ AF: 0.448

Gnomad EAS AF: 0.464

Gnomad SAS AF: 0.616

Gnomad FIN AF: 0.330

Gnomad MID AF: 0.490

Gnomad NFE AF: 0.378

Gnomad OTH AF: 0.438

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.470 AC: 71436 AN: 151960 Hom.: 18238 Cov.: 32 AF XY: 0.471 AC XY: 35003 AN XY: 74278

African (AFR) AF: 0.680 AC: 28160 AN: 41430

American (AMR) AF: 0.377 AC: 5761 AN: 15266

Ashkenazi Jewish (ASJ) AF: 0.448 AC: 1557 AN: 3472

East Asian (EAS) AF: 0.465 AC: 2398 AN: 5158

South Asian (SAS) AF: 0.616 AC: 2965 AN: 4816

European-Finnish (FIN) AF: 0.330 AC: 3483 AN: 10562

Middle Eastern (MID) AF: 0.507 AC: 148 AN: 292

European-Non Finnish (NFE) AF: 0.378 AC: 25696 AN: 67944

Other (OTH) AF: 0.438 AC: 924 AN: 2110

Alfa AF: 0.412 Hom.: 4755

Bravo AF: 0.475

Asia WGS AF: 0.515 AC: 1792 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.96
CADD	Benign	7.2
DANN	Benign	0.58
PhyloP100		0.47
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs1476214; hg19: chr4-123813009;